Idexx Laboratories
IDXX
956 hedge funds and large institutions have $25.9B invested in Idexx Laboratories in 2022 Q2 according to their latest regulatory filings, with 92 funds opening new positions, 336 increasing their positions, 370 reducing their positions, and 156 closing their positions.
1.42% more ownership
Funds ownership: 86.45% → 87.87% (+1.4%)
2% less call options, than puts
Call options by funds: $109M | Put options by funds: $112M
9% less repeat investments, than reductions
Existing positions increased: 336 | Existing positions reduced: 370
7% less funds holding
Funds holding: 1,032 → 956 (-76)
25% less funds holding in top 10
Funds holding in top 10: 28 → 21 (-7)
35% less capital invested
Capital invested by funds: $39.7B → $25.9B (-$13.9B)
41% less first-time investments, than exits
New positions opened: 92 | Existing positions closed: 156
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Select Equity Group
New York
|
+$433M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$381M |
| 3 |
AllianceBernstein
Nashville,
Tennessee
|
+$342M |
| 4 |
Morgan Stanley
New York
|
+$181M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$156M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$297M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$148M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$124M |
| 4 |
Principal Financial Group
Des Moines,
Iowa
|
-$104M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$88.8M |
IDXX Hedge Fund Activity: Q2 2022 in Review
956 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Idexx Laboratories (IDXX) for Q2 2022, worth a combined $25.9B — down 35% from $39.7B a quarter earlier.
Sellers outnumbered buyers: 156 funds closed out of IDXX and 92 opened new positions — a net loss of 64 holders — while 370 trimmed existing stakes and 336 added.
The largest buyer was Select Equity Group, adding an estimated $433M. The largest seller was BlackRock, cutting an estimated $297M.
- 956 institutional investors held Idexx Laboratories (IDXX) as of Q2 2022, down from 1,032 in Q1 2022.
- Funds reported $25.9B of Idexx Laboratories stock for Q2 2022, down 35% quarter-over-quarter.
- 92 funds opened new Idexx Laboratories positions in Q2 2022 and 156 closed out, a net change of -64 holders.
- The largest Idexx Laboratories buyer in Q2 2022 was Select Equity Group, an estimated $433M added.
- The largest Idexx Laboratories seller in Q2 2022 was BlackRock, an estimated $297M sold.
Based on aggregated 13F filings for Q2 2022.